Association of rs670 variant of APOA-1 gene with cardiometabolic markers after consuming sesame, canola and sesame-canola oils in adults with and without type 2 diabetes mellitus
- PMID: 32690147
- DOI: 10.1016/j.clnesp.2020.05.016
Association of rs670 variant of APOA-1 gene with cardiometabolic markers after consuming sesame, canola and sesame-canola oils in adults with and without type 2 diabetes mellitus
Abstract
Background & aims: The inter-individual variations of the metabolic markers in response to dietary interventions may be mediated by genetic factors. We examined whether the type of dietary oils can modulate the effects of -75G/A polymorphism in APOA-1 gene on cardiometabolic markers.
Methods: This study was a randomized, triple-blind, cross-over clinical trial. Participants with and without type 2 diabetes were randomly assigned to replace their regular oil with sesame oil, canola oil and sesame-canola oil for 9 weeks. Genotyping was conducted using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.
Results: Ninety-five diabetes patients and 73 healthy individuals completed the study protocol. In patients with type 2 diabetes, the A allele carriers experienced greater decrease in systolic blood pressure compared with GG homozygotes following sesame-canola oil intake. Serum levels of HDL-C and TG: HDL ratio was increased and decreased following canola oil intake in patients carrying the A allele rather than non-A allele carriers, respectively. More reductions for risk of cardiovascular diseases and mortality, except risk of stroke were found in the A allele carriers compared with GG homozygotes after intakes of canola and sesame-canola oils, but not sesame oil. There was also a significant genotype effect as well as genotype-dietary oil interactions on cardiovascular risk scores. In healthy individuals, a considerable decrease in visceral fat was accompanied by a significant increase in HDL-C levels in the A allele carriers compared with non-A allele carriers after sesame oil intake.
Conclusion: Patients with diabetes carrying the A allele might benefit from canola and sesame-canola oils intakes, and healthy A allele carriers from sesame and sesame-canola oils intakes as well. Future clinical trials are recommended to warrant current findings.
Keywords: Apolipoprotein A-I; Cardiovascular risk factors; Genetic polymorphism; Rapeseed oil; Sesame oil; Type 2 diabetes mellitus.
Copyright © 2020 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The study was jointly funded by Shahid Sadoughi University of Medical Sciences (http://www.ssu.ac.ir) and Datis Corporation (http://www.neshatavar.com/?l=EN). Datis Corporation provided all of the intervention dietary oils consumed during the study. The investigators state that they did not have a direct financial relationship with Datis Corporation. Shahid Sadoughi University of Medical Sciences received the funds and delivered it to the investigators. Datis Corporation had no role in design and conduction of the study, data collection, data management, analysis and interpretation of the data, and also preparation of this manuscript. Datis Corporation did not have any other relationship with the investigators. The authors declare that they have no other potential personal or financial conflicts of interest. The principal investigator (ASA) declares that he has full access to the data provided by this project.
Similar articles
-
Cardiometabolic risk factors are affected by interaction between FADS1 rs174556 variant and dietary vegetable oils in patients with diabetes: a randomized controlled trial.Sci Rep. 2024 Nov 11;14(1):27531. doi: 10.1038/s41598-024-78294-6. Sci Rep. 2024. PMID: 39528535 Free PMC article. Clinical Trial.
-
The effects of sesame, canola, and sesame-canola oils on cardiometabolic markers in patients with type 2 diabetes: a triple-blind three-way randomized crossover clinical trial.Eur J Nutr. 2022 Oct;61(7):3499-3516. doi: 10.1007/s00394-022-02898-9. Epub 2022 May 21. Eur J Nutr. 2022. PMID: 35596008 Clinical Trial.
-
The combined effects of cholesteryl ester transfer protein (CETP) TaqIB gene polymorphism and canola, sesame and sesame-canola oils consumption on metabolic response in patients with diabetes and healthy people.J Cardiovasc Thorac Res. 2020;12(3):185-194. doi: 10.34172/jcvtr.2020.32. Epub 2020 Aug 2. J Cardiovasc Thorac Res. 2020. PMID: 33123324 Free PMC article.
-
The effects of Canola oil on cardiovascular risk factors: A systematic review and meta-analysis with dose-response analysis of controlled clinical trials.Nutr Metab Cardiovasc Dis. 2020 Nov 27;30(12):2133-2145. doi: 10.1016/j.numecd.2020.06.007. Epub 2020 Jun 18. Nutr Metab Cardiovasc Dis. 2020. PMID: 33127255
-
Effects of Canola Oil Consumption on Lipid Profile: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.J Am Coll Nutr. 2019 Feb;38(2):185-196. doi: 10.1080/07315724.2018.1475270. Epub 2018 Oct 31. J Am Coll Nutr. 2019. PMID: 30381009
Cited by
-
Cardiometabolic risk factors are affected by interaction between FADS1 rs174556 variant and dietary vegetable oils in patients with diabetes: a randomized controlled trial.Sci Rep. 2024 Nov 11;14(1):27531. doi: 10.1038/s41598-024-78294-6. Sci Rep. 2024. PMID: 39528535 Free PMC article. Clinical Trial.
-
The effects of sesame, canola, and sesame-canola oils on cardiometabolic markers in patients with type 2 diabetes: a triple-blind three-way randomized crossover clinical trial.Eur J Nutr. 2022 Oct;61(7):3499-3516. doi: 10.1007/s00394-022-02898-9. Epub 2022 May 21. Eur J Nutr. 2022. PMID: 35596008 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous